Karaolanis GI, Lionaki S, Moris D, Palla V, Vernadakis S. Secondary hyperoxaluria: a risk factor for kidney stone formation and renal failure in native kidneys and renal grafts. Transplantation Reviews 2014; 28(4): 182–187.
Nematollahi P, Mohammadizadeh F. Primary hyperoxaluria diagnosed based on bone marrow biopsy in pancytopenic adult with end stage renal disease. Case Rep Hematol. 2015; 2015: 402947.
Nachite F et al. Primary hyperoxaluria detected by bone marrow biopsy: Case report. BMC Clin Pathol. 2017 Sep 20; 17: 20.
Sharma S et al. Bone marrow oxalosis: An unusual cause of cytopenia in end-stage renal disease; report of two cases. Indian J Pathol Microbiol. 2018; 61: 268–70.
Hoppe B. An update on primary hyperoxaluria. Nat Rev Nephrol. 2012; 8: 467–475.
Milliner DS, Harris PC, Cogal AG, et al. Primary Hyperoxaluria Type 1. 2002 Jun 19 [Updated 2017 Nov 30]. In: Adam MP, Ardinger HH, Pagon RA, et al. (eds). GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1283/
Rumsby G, Hulton SA. Primary Hyperoxaluria Type 2. 2008 Dec 2 [Updated 2017 Dec 21]. In: Adam MP, Ardinger HH, Pagon RA, et al. (eds). GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK2692/
Milliner DS, Harris PC, Lieske JC. Primary Hyperoxaluria Type 3. 2015 Sep 24. In: Adam MP, Ardinger HH, Pagon RA, et al. (eds). GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. Available from: https://www.ncbi.nlm.nih.gov/sites/books/NBK316514/
Hopp K, Cogal AG, Bergstralh EJ, et al. Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria. J Am Soc Nephrol. 2015; 26(10): 2559–2570.